Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
-
-
-
-
-
-
Pfizer Prices $4,000,000,000 Debt Offering
-
-
-
-
-
-
-
Deutsche Bank Raises Pfizer (PFE) PT Prior To tafamidis Data
-
-
-
-
-
-
-
Pfizer Prices $1,065,000,000 Debt Offering
-
-
-
-
-
-
-
AstraZeneca asthma drug hits goal, to enter competitive market
-
-
-
-
-
-
-
Deutsche Bank Says Pfizer (PFE) and Allergan (AGN) Deal Would Enhance Cash Access
-
-
-
-
-
-
-
Notable Analyst Rating Changes 05/28: (COP) (TWTR) (AUXL) Upgraded; (DG) (LOW) (VOD) Downgraded
-
-
-
-
-
-
-
Notable Analyst Rating Changes 07/10: (WLT) (HPQ) (CLF) Upgraded; (WFC) (NEM) (NSC) Downgraded
-
55,950 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

